Robert Shorr Insider Profile
4 Followers
Robert Shorr, Director at Brainstorm Cell Therapeutics, holds 45.73K shares in Brainstorm Cell Therapeutics (Ticker: BCLI).
Robert Shorr's Trading History
| BCLIBrainstorm Cell Therapeutics | Nov 13, 2017 | Director | Uninformative Buy | ― | $45.27K | |
BCLI Insider Shares: 45.73K (0.24%) | ||||||
You May Also Like
Robert Shorr insider profile FAQ
What is the percentage of profitable transactions made by Robert Shorr?
The percentage of profitable transactions made by Robert Shorr is 50%.
What is the average return per transaction made by Robert Shorr?
The average return per transaction made by Robert Shorr is 0.50%.
What stocks does Robert Shorr hold?
Robert Shorr holds: BCLI stocks.
What was Robert Shorr's most profitable transaction?
Robert Shorr’s most profitable transaction was an Informative Sell of BCLI stock on December 17, 2015. The return on the trade was 2.10%.
What is Robert Shorr's role in Brainstorm Cell Therapeutics?
Robert Shorr's role in Brainstorm Cell Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
